Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDPasithea Therapeutics Corp. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
Pasithea Therapeutics Corp. Earnings Date And Information
Pasithea Therapeutics Corp. last posted its earnings results on Thursday, March 28th, 2024. The company reported $-4.84663 earnings per share for the quarter, missing analysts' consensus estimates of $-3.8 by $1.04663. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Pasithea Therapeutics Corp. has generated $-12,686 earnings per share over the last year ($-12685.72 diluted earnings per share) and currently has a price-to-earnings ratio of -0.1. Pasithea Therapeutics Corp. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based on prior year's report dates.
Pasithea Therapeutics Corp. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/24/2025 | Q4 2024 | N/A | -$2.90 | N/A | N/A | $0 |
| 11/13/2024 | Q3 2024 | N/A | -$2.87 | N/A | $0 | $0 |
| 08/13/2024 | Q2 2024 | N/A | -$3.71 | N/A | $0 | $0 |
| 05/14/2024 | Q1 2024 | N/A | -$3.70 | N/A | N/A | $0 |
| 03/28/2024 | Q4 2023 | N/A | -$4.85 | N/A | N/A | $976,306 |
| 11/13/2023 | Q3 2023 | N/A | -$2.87 | N/A | N/A | $0 |
| 08/11/2023 | Q2 2023 | -$3.40 | -$2.88 | 0.52 | N/A | $0 |
| 05/12/2023 | Q1 2023 | -$3.40 | -$211.05 | -207.65 | N/A | $0 |
| 03/30/2023 | Q4 2022 | -$3.40 | -$3.00 | 0.4 | N/A | $240,712 |
| 11/14/2022 | Q3 2022 | -$3.40 | -$3.45 | -0.05 | $200,000 | $218,608 |
| 08/15/2022 | Q2 2022 | -$2.20 | -$0.08 | 2.12 | N/A | $13,581 |
| 05/16/2022 | Q1 2022 | -$0.02 | $0.00 | 0.02 | N/A | $13,658 |
| 03/30/2022 | Q4 2021 | -$0.05 | $0.06 | 0.11 | N/A | $15,062 |
| 11/18/2021 | Q3 2021 | N/A | -$0.17 | N/A | N/A | $0 |
| 06/30/2021 | Q2 2021 | N/A | -$0.07 | N/A | N/A | $0 |
| 03/31/2021 | Q1 2021 | N/A | -$0.04 | N/A | N/A | $0 |
| 12/31/2020 | Q4 2020 | N/A | -$0.13 | N/A | N/A | $0 |
| 09/30/2020 | Q3 2020 | N/A | -$0.00 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Pasithea Therapeutics Corp. Earnings: FAQ's
Pasithea Therapeutics Corp. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based offlast year's report dates.
The conference call for Pasithea Therapeutics Corp.'s latest earnings report can be listened to online.
The conference call transcript for Pasithea Therapeutics Corp.'s latest earnings report can be read online.
Pasithea Therapeutics Corp. (:KTTA) has a recorded net income of $-13,904,584,000.Pasithea Therapeutics Corp. has generated $-12685.72 earnings per share over the last four quarters.
Pasithea Therapeutics Corp. (:KTTA) has a price-to-earnings ratio of -0.1 and price/earnings-to-growth ratio is -0.